Cameron R. Nelson
Financieel Directeur/CFO bij Mati Therapeutics, Inc.
Actieve functies van Cameron R. Nelson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Mati Therapeutics, Inc.
 Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Financieel Directeur/CFO | - | - |
Loopbaan van Cameron R. Nelson
Eerdere bekende functies van Cameron R. Nelson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Comptroller/Controller/Auditor | 24-05-2010 | 30-11-2011 |
| Financieel Directeur/CFO | 01-05-2000 | 09-07-2012 |
Opleiding van Cameron R. Nelson
| Dartmouth College | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Statistieken
Internationaal
| Canada | 3 |
| Verenigde Staten | 3 |
Operationeel
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Mati Therapeutics, Inc.
Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Health Technology |
- Beurs
- Insiders
- Cameron R. Nelson
- Ervaring
